Regulation of mitotic function of Chk1 through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdk1)

被引:46
作者
Shiromizu, T
Goto, H [1 ]
Tomono, Y
Bartek, J
Totsukawa, G
Inoko, A
Nakanishi, M
Matsumura, F
Inagaki, M
机构
[1] Aichi Canc Ctr, Res Inst, Div Biochem, Aichi 4648681, Japan
[2] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA
[3] Shigei Med Res Inst, Div Cell & Mol Biol, Okayama 7010202, Japan
[4] Danish Canc Soc, Inst Canc Biol, Dept Cell Cycle & Canc, DK-2100 Copenhagen, Denmark
[5] Nagoya City Univ, Sch Med, Aichi 4678601, Japan
关键词
D O I
10.1111/j.1365-2443.2006.00955.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chk1 is phosphorylated at Ser317 and Ser345 by ATR in response to stalled replication and genotoxic stresses. This Chk1 activation is thought to play critical roles in the prevention of premature mitosis. However, the behavior of Chk1 in mitosis remains largely unknown. Here we reported that Chk1 was phosphorylated in mitosis. The reduction of this phosphorylation was observed at the metaphase-anaphase transition. Two-dimensional phosphopeptide mapping revealed that Chk1 phosphorylation sites in vivo were completely overlapped with the in vitro sites by cyclin-dependent protein kinase (Cdk) 1 or by p38 MAP kinase. Ser286 and Ser301 were identified as novel phosphorylation sites on Chk1. Treatment with Cdk inhibitor butyrolactone I induced the reduction of Chk1-S301 phosphorylation, although treatment with p38-specific inhibitor SB203580 or siRNA did not. In addition, ionizing radiation (IR) or ultraviolet (UV) light did not induce Chk1 phosphorylation at Ser317 and Ser345 in nocodazole-arrested mitotic cells. These observations imply the regulation of mitotic Chk1 function through Chk1 phosphorylation at novel sites by Cdk1.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 33 条
[11]   Cell cycle-dependent and ATM-independent expression of human Chk1 kinase [J].
Kaneko, Y ;
Watanabe, N ;
Morisaki, H ;
Akita, H ;
Fujimoto, A ;
Tominaga, K ;
Terasawa, M ;
Tachibana, A ;
Ikeda, K ;
Nakanishi, M .
ONCOGENE, 1999, 18 (25) :3673-3681
[12]   Cell-cycle checkpoints and cancer [J].
Kastan, MB ;
Bartek, J .
NATURE, 2004, 432 (7015) :316-323
[13]  
Kawajiri A, 2004, METHOD CELL BIOL, V78, P353
[14]  
KITAGAWA M, 1993, ONCOGENE, V8, P2425
[15]  
LANDRY J, 1992, J BIOL CHEM, V267, P794
[16]   p38 mitogen-activated protein kinase inhibitors - Mechanisms and therapeutic potentials [J].
Lee, JC ;
Kassis, S ;
Kumar, S ;
Badger, A ;
Adams, JL .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) :389-397
[17]   Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells [J].
Matsusaka, T ;
Pines, J .
JOURNAL OF CELL BIOLOGY, 2004, 166 (04) :507-516
[18]   Distantly related cousins of MAP kinase: Biochemical properties and possible physiological functions [J].
Miyata, Y ;
Nishida, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (02) :291-295
[19]   Cdc25A Regulation To Destroy or Not To Destroy-Is That the Only Question? [J].
Neely, Kristen E. ;
Piwnica-Worms, Helen .
CELL CYCLE, 2003, 2 (05) :455-457
[20]   Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains [J].
Ng, CP ;
Lee, HC ;
Ho, CW ;
Arooz, T ;
Siu, WY ;
Lau, A ;
Poon, RYC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :8808-8819